Optimizing IFN Beta - 1B Dose
NCT00473213
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
217
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
Interferon Beta 1
Sponsor
University of Turin, Italy
Collaborators
[object Object]